See more funds from Majedie Asset Management
See more funds in the UK All Companies sector
See more funds managed by: Matthew Smith
Majedie UK Focus A
Fund Overview |
|
|---|---|
| Unit Price |
321.21p
24/05/2012 |
| Standard Initial Charge | n/a |
| TQ Invest Discount | 0.00% |
| Initial Charge Through TQ Invest | n/a |
| Annual Management Charge | 2.00% |
| Total Expense Ratio | 2.04% |
| Fund size | £243,227,008 |
| Usable in ISA | No |
Fund holding information
| Holding | Weighting |
|---|---|
| Bp | 6.48% |
| Barclays | 5.58% |
| Glaxosmithkline | 4.81% |
| Bae Systems | 4.39% |
| International Consolidated Airl Grp | 4.02% |
| Vodafone Group | 4.00% |
| Itv | 3.56% |
| Astrazeneca Plc | 3.52% |
| Bt Group | 3.34% |
| Pearson | 2.94% |
| Sector | Weighting |
|---|---|
| Services | 21.79% |
| Financials | 20.46% |
| Industrials | 14.15% |
| Oil & Gas | 13.65% |
| Telecom, Media & Technology | 10.93% |
| Health Care | 8.33% |
| Money Market | 6.06% |
| Basic Materials | 2.65% |
| Utilities | 1.98% |
| Region | Weighting |
|---|---|
| Uk | 93.94% |
| Money Market | 6.06% |
| Asset Type | Weighting |
|---|---|
| Uk Equities | 93.94% |
| Money Market | 6.06% |
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.